Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma

被引:45
作者
Giehl, K. A. [1 ]
Naegle, U. [1 ]
Volkenandt, M. [1 ]
Berking, C. [1 ]
机构
[1] Univ Munich, Dept Dermatol, D-80337 Munich, Germany
关键词
D O I
10.1111/j.1600-0560.2006.00569.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Basic fibroblast growth factor ( bFGF) and stem cell factor (SCF) are essential growth factors for melanocytes which carry the receptors FGFR-1 for bFGF and c-kit for SCF. Because both factors may be involved in melanoma development, the expression of bFGF/FGFR-1 and SCF/c-kit was investigated in melanocytic tumors of different progression stages. Methods: Fifty primary melanomas and 44 melanocytic nevi were analyzed for the expression of SCF, c-kit, bFGF, and FGFR- 1 by immunohistochemistry. Results: In melanoma, SCF and c-kit were expressed in 76 and 84%, respectively, and coexpressed in 66%. bFGF and FGFR-1 were expressed in 45 and 86%, respectively, and coexpressed in 46%. In melanocytic nevi, SCF was expressed in 23% and c-kit in 70% while coexpression was more common in dysplastic (39%) than non-dysplastic subtypes (8%). bFGF and FGFR-1 were expressed in 55 and 67%, respectively, while coexpression was found in 47% but varied considerably between different histological subtypes. Conclusions: SCF and c-kit were frequently expressed by melanomas and dysplastic nevi suggesting an autocrine growth mechanism as described for bFGF. In both nevi and melanoma, c-kit was almost exclusively found in the epidermis while bFGF was more common in the dermis. Thus the growth factor/receptor expression seems to depend on the cutaneous localization of the melanocytic tumors.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 37 条
[1]   Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma [J].
Ahmed, NU ;
Ueda, M ;
Ito, A ;
Ohashi, A ;
Funasaka, Y ;
Ichihashi, M .
MELANOMA RESEARCH, 1997, 7 (04) :299-305
[2]   The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma [J].
AlAlousi, S ;
Barnhill, R ;
Blessing, K ;
Barksdale, S .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (06) :506-510
[3]   Expression of basic fibroblast growth factor in desmoplastic melanoma [J].
AlAlousi, S ;
Carlson, JA ;
Blessing, K ;
Cook, M ;
Karaoli, T ;
Barnhill, RL .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (02) :118-125
[4]   FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes [J].
Alanko, T ;
Rosenberg, M ;
Saksela, O .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (01) :111-116
[5]  
ALBINO AP, 1991, CANCER RES, V51, P4815
[6]   An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients [J].
Alexis, JB ;
Martinez, AE ;
Lutzky, J .
MELANOMA RESEARCH, 2005, 15 (04) :283-285
[7]   PROLIFERATION OF HUMAN-MALIGNANT MELANOMAS IS INHIBITED BY ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETED AGAINST BASIC FIBROBLAST GROWTH-FACTOR [J].
BECKER, D ;
MEIER, CB ;
HERLYN, M .
EMBO JOURNAL, 1989, 8 (12) :3685-3691
[8]   Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B [J].
Berking, C ;
Takemoto, R ;
Satyamoorthy, K ;
Shirakawa, T ;
Eskandarpour, M ;
Hansson, J ;
VanBelle, PA ;
Elder, DE ;
Herlyn, M .
CANCER RESEARCH, 2004, 64 (03) :807-811
[9]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[10]   Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients [J].
Birck, A ;
Kirkin, AF ;
Zeuthen, J ;
Hou-Jensen, K .
MELANOMA RESEARCH, 1999, 9 (04) :375-381